Ifp Advisors, Inc Repligen Corp Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Repligen Corp stock. As of the latest transaction made, Ifp Advisors, Inc holds 14 shares of RGEN stock, worth $1,746. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 10 40.0%

Holding current value

$1,746

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$120.0 - $182.95 $480 - $731	4 Added 40.0%	14 $1,000
Q1 2024 Jul 30, 2024	BUY	$170.78 - $208.42 $1,537 - $1,875	9 Added 900.0%	10 $1,000
Q4 2023 Jan 09, 2024	BUY	$114.17 - $185.35 $114 - $185	1 New	1 $0
Q1 2023 Apr 18, 2023	SELL	$154.26 - $198.1 $29,926 - $38,431	-194 Reduced 84.35%	36 $6,000
Q4 2022 Feb 07, 2023	BUY	$162.42 - $220.56 $487 - $661	3 Added 1.32%	230 $53,000
Q3 2022 Nov 08, 2022	BUY	$160.42 - $256.21 $9,304 - $14,860	58 Added 34.32%	227 $51,000
Q2 2022 Sep 06, 2022	BUY	$140.68 - $188.02 $23,774 - $31,775	169 New	169 $39,000
Q2 2022 Aug 12, 2022	SELL	$140.68 - $188.02 $23,774 - $31,775	-169 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$161.19 - $257.96 $6,286 - $10,060	39 Added 30.0%	169 $31,000
Q1 2022 Aug 08, 2022	BUY	$161.19 - $257.96 $644 - $1,031	4 Added 3.17%	130 $24,000
Q4 2021 Jan 12, 2022	SELL	$247.59 - $304.47 $346,130 - $425,649	-1,398 Reduced 91.73%	126 $35,000
Q3 2021 Oct 06, 2021	SELL	$194.77 - $324.21 $26,878 - $44,740	-138 Reduced 8.3%	1,524 $441,000
Q2 2021 Jul 13, 2021	SELL	$165.87 - $220.95 $123,241 - $164,165	-743 Reduced 30.89%	1,662 $334,000
Q1 2021 Apr 30, 2021	SELL	$180.37 - $226.26 $27,416 - $34,391	-152 Reduced 5.94%	2,405 $471,000
Q4 2020 Jan 25, 2021	BUY	$148.08 - $206.57 $164,368 - $229,292	1,110 Added 76.71%	2,557 $489,000
Q3 2020 Oct 29, 2020	SELL	$122.51 - $158.27 $4,777 - $6,172	-39 Reduced 2.62%	1,447 $214,000
Q2 2020 Aug 05, 2020	SELL	$94.33 - $140.48 $1,226 - $1,826	-13 Reduced 0.87%	1,486 $176,000
Q1 2020 May 12, 2020	SELL	$84.96 - $109.14 $6,202 - $7,967	-73 Reduced 4.64%	1,499 $138,000
Q4 2019 Jan 17, 2020	SELL	$73.84 - $93.08 $147 - $186	-2 Reduced 0.13%	1,572 $148,000
Q3 2019 Nov 07, 2019	BUY	$76.65 - $95.51 $120,647 - $150,332	1,574 New	1,574 $122,000
Q1 2019 May 15, 2019	SELL	$49.45 - $62.8 $69,230 - $87,920	-1,400 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$48.26 - $68.88 $5,163 - $7,370	-107 Reduced 7.1%	1,400 $73,000
Q4 2016 Jun 03, 2019	BUY	N/A	107 Added 7.64%	1,507 $46,000
Q2 2016 Jun 03, 2019	BUY	N/A	1,400	1,400 $38,000

Others Institutions Holding RGEN

# of Institutions

487

Shares Held

54.4M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account